202 related articles for article (PubMed ID: 24011542)
1. Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate.
Annweiler C; Brugg B; Peyrin JM; Bartha R; Beauchet O
Neurobiol Aging; 2014 Feb; 35(2):331-5. PubMed ID: 24011542
[TBL] [Abstract][Full Text] [Related]
2. Memantine plus vitamin D prevents axonal degeneration caused by lysed blood.
Charier D; Beauchet O; Bell M; Brugg B; Bartha R; Annweiler C
ACS Chem Neurosci; 2015 Mar; 6(3):393-7. PubMed ID: 25587803
[TBL] [Abstract][Full Text] [Related]
3. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
4. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
5. Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.
Annweiler C; Beauchet O
Drugs Aging; 2012 Feb; 29(2):81-91. PubMed ID: 22233455
[TBL] [Abstract][Full Text] [Related]
6. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
[TBL] [Abstract][Full Text] [Related]
7. [Vitamin D and Alzheimer's disease: from an intriguing idea to a therapeutic option].
Annweiler C
Biol Aujourdhui; 2014; 208(1):89-95. PubMed ID: 24948022
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G
Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study.
Annweiler C; Herrmann FR; Fantino B; Brugg B; Beauchet O
Cogn Behav Neurol; 2012 Sep; 25(3):121-7. PubMed ID: 22960436
[TBL] [Abstract][Full Text] [Related]
10. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
Danysz W; Parsons CG
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747
[TBL] [Abstract][Full Text] [Related]
11. Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: comparison with memantine.
Hemmati F; Dargahi L; Nasoohi S; Omidbakhsh R; Mohamed Z; Chik Z; Naidu M; Ahmadiani A
Behav Brain Res; 2013 Sep; 252():415-21. PubMed ID: 23777795
[TBL] [Abstract][Full Text] [Related]
12. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
[TBL] [Abstract][Full Text] [Related]
13. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model.
Chen TF; Huang RF; Lin SE; Lu JF; Tang MC; Chiu MJ
J Alzheimers Dis; 2010; 20(2):607-15. PubMed ID: 20164552
[TBL] [Abstract][Full Text] [Related]
14. Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
Wong D; Broberg DN; Doad J; Umoh JU; Bellyou M; Norley CJD; Holdsworth DW; Montero-Odasso M; Beauchet O; Annweiler C; Bartha R
J Alzheimers Dis; 2021; 81(1):375-388. PubMed ID: 33780366
[TBL] [Abstract][Full Text] [Related]
15. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury.
Liu C; Lin N; Wu B; Qiu Y
Brain Res; 2009 Jul; 1282():173-82. PubMed ID: 19501064
[TBL] [Abstract][Full Text] [Related]
17. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Doraiswamy PM
CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
[TBL] [Abstract][Full Text] [Related]
18. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
[TBL] [Abstract][Full Text] [Related]
19. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
20. Effects of Memantine and High Dose Vitamin D on Gait in Male APP/PS1 Alzheimer's Disease Mice Following Vitamin D Deprivation.
Broberg DN; Wong D; Bellyou M; Montero-Odasso M; Beauchet O; Annweiler C; Bartha R
J Alzheimers Dis; 2022; 85(4):1755-1766. PubMed ID: 34958027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
